-

STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of TaskUs, Inc. (TASK) and Encourages Long-Term Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating TaskUs, Inc. (NASDAQ: TASK) on behalf of the company’s long-term investors.

Recently an amended securities fraud complaint was filed against TaskUs on behalf of certain investors who purchased shares of the company’s stock between June 11, 2021 and January 19, 2022. According to the complaint, during that time period TaskUs and certain of the company’s senior executive officers made a series of materially false and misleading statements concerning two key human capital (the core of TaskUs’ business) metrics: (i) TaskUs’s employee attrition rate and (ii) its rating on Glassdoor.

As detailed in the complaint, on January 20, 2022, Spruce Point Capital Management, LLC (“Spruce Point”) issued a report on TaskUs titled “Moderating the Bull Case Content” (the “Report”). Based on a “forensic financial and accounting review” of TaskUs and interviewing former TaskUs executives and employees, Spruce Point concluded that “TASK’s claim of a superior corporate culture evidenced by below industry standard workforce attrition appear[s] to be highly exaggerated.” Following the issuance of this Report, shares of TaskUs’ common stock declined $6.80 per share, or nearly 20% in value, to close on January 21, 2022 at $28.79 per share.

The investigation seeks to determine whether the members of TaskUs’ board of directors violated the securities laws and/or breached their fiduciary duties in connection with the above alleged misconduct.

TaskUs shareholders who purchased or acquired their shares prior to August 10, 2021 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 or (888) 715 – 1740, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/taskus/ , for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NASDAQ:TASK

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal”) on behalf of the company’s current shareholders. The investigation seeks to determine whether Amneal or the company’s officers and/or directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Amneal shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional infor...

Kaskela Law Firm Announces Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating DexCom, Inc. (Nasdaq: DXCM) on behalf of the company’s long-term investors. Click here for additional information: https://kaskelalaw.com/case/dexcom-inc/ Recently a securities fraud complaint was filed against DexCom on behalf of investors who purchased shares of the company's stock between January 8, 2024 and September 17, 2025 (the “Wrongdoing Period”). According to the complaint, during th...

Kaskela Law Firm Announces Investigation of Fortrea Holdings Inc. (FTRE) and Encourages Long-Term FTRE Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Fortrea Holdings Inc. (Nasdaq: FTRE) (“Fortrea”) on behalf of the company’s long-term investors. Click here for additional information: https://kaskelalaw.com/case/fortrea-holdings/ Recently a securities fraud complaint was filed against Fortrea on behalf of certain investors who purchased shares of the company’s stock between July 5, 2023 and February 28, 2025 (the “Wrongdoing Period”). Accor...
Back to Newsroom